KC Pharma SRL
KC Pharma reported total assets of 873,296 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of KC Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +26 % Total assets +21 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
KC Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 115,605 € | ||||
| Equity | 736,030 € | ||||
| Cash | 11,932 € | ||||
| EBITDA | 157,850 € | ||||
| Total assets | 873,296 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
KC Pharma's financial analysis
- Solvency84.3%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of KC Pharma
KC Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.334.705
- VAT number
- BE0479334705
- Peppol
- Registered · 0208:0479334705 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jan 2003
- Registered office
- 2400 Mol
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
KC Pharma (SRL) has been based in Mol since 2003, active in: business and other management consultancy activities. For 2025, it reports a net profit of 115,605 € and equity of 736,030 €; its revenue is not published. Its solvency stands at 84.3%, above the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to KC Pharma
Companies in the same business, of comparable size and area, outside its group.
- AscensuS Business and other management consultancy activities Tielt-Winge · balance sheet 870,092 €
- Wilkinson Development Business and other management consultancy activities Nijlen · balance sheet 879,802 €
- Cologic Business and other management consultancy activities Maaseik · balance sheet 860,436 €
- FD Projects Business and other management consultancy activities Aalter · balance sheet 860,409 €
- Skarabee Business and other management consultancy activities Oud-Turnhout · balance sheet 887,302 €
- Piramide Business and other management consultancy activities Sint-Martens-Latem · balance sheet 858,871 €
- H&C Business and other management consultancy activities Sint-Martens-Latem · balance sheet 888,323 €
- Inkofin Business and other management consultancy activities Hove · balance sheet 889,299 €
Frequently asked questions about KC Pharma
What is the revenue of KC Pharma?
KC Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of KC Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0479334705 for KC Pharma, if the company is VAT-registered. Its company number (CBE) is 0479.334.705.
Where is the registered office of KC Pharma?
According to the CBE register, the registered office of KC Pharma is in 2400 Mol.
What is the equity of KC Pharma?
At the close of the 2025 financial year, the equity of KC Pharma amounts to 736,030 €, a solvency of 84.3% of total assets.
Who manages KC Pharma?
The register lists 1 active mandates at KC Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of KC Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →